SINGLE-DOSE PHARMACOKINETICS OF CARBAMAZEPINE-10,11-EPOXIDE IN PATIENTS ON LAMOTRIGINE MONOTHERAPY

Citation
F. Pisani et al., SINGLE-DOSE PHARMACOKINETICS OF CARBAMAZEPINE-10,11-EPOXIDE IN PATIENTS ON LAMOTRIGINE MONOTHERAPY, Epilepsy research, 19(3), 1994, pp. 245-248
Citations number
14
Categorie Soggetti
Clinical Neurology
Journal title
ISSN journal
09201211
Volume
19
Issue
3
Year of publication
1994
Pages
245 - 248
Database
ISI
SICI code
0920-1211(1994)19:3<245:SPOCIP>2.0.ZU;2-L
Abstract
The pharmacokinetics of a single oral dose of carbamazepine-10,11-epox ide (CBZ-E, 100 mg) were compared in 10 patients on chronic monotherap y with lamotrigine (LTG, 200-300 mg/day) and in 10 drug-free healthy c ontrol subjects. CBZ-E pharmacokinetic parameters in LTG-treated patie nts were found to be similar to those observed in controls (half-life: 7.2 +/- 1.6 vs 6.1 +/- 0.9 h; apparent oral clearance: 110.8 +/- 53.1 vs 120.5 +/- 29.9 ml/h/kg; apparent volume of distribution: 1.08 +/- 0.37 vs 1.04 +/- 0.25 l/kg respectively; means +/- s.d.). These data i ndicate that, contrary to previous suggestions, LTG has no effect on t he metabolic disposition of CBZ-E.